Twitter Facebook LinkedIn YouTube

Blueberries Medical Corp. (CSE:BBM) New Listing

Video Platform Video Management Video Solutions Video Player

Blueberries Medical, through wholly-owned subsidiary Blueberries SAS, is seeking to become a large-scale producer of naturally grown premium quality cannabis in central Colombia.

Additional Information:

Company: Blueberries Medical Corp.
Website: http://www.blueberriesmed.com,
Stock Symbol: CSE: BBM
Date Published: Feb 7, 2019
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

Blueberries Medical Corp is one of the latest new listing on the Canadian Securities Exchange, trading under the symbol “BBM”, following the reverse take-over of CDN MSolar Corp.

Blueberries Medical, through wholly-owned subsidiary Blueberries SAS, is seeking to become a large-scale producer of naturally grown premium quality cannabis in central Colombia.

The property is located in the Bogota savannah, one of the safest areas in Colombia, and the major production center of cut flowers in Colombia.

The company has pre-registered and owns 134 exclusive Colombian cannabis strains with high contents of CBD and THC.

These strains have been tested by the company’s master grower in different climates, altitudes and regions of Colombia.

Led by an expert team in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries SAS has received all the licences required for the cultivation, production, domestic distribution and international export of CBD and THC-based medical cannabis.

Blueberries will have an initial effective crop area of approximately 10,000 square meters, which is estimated to allow for production of over 5.4 tonnes of dry cannabis flower annually.

Blueberries SAS anticipates generating its first commercial crop harvest during 2019 with commercial sale of CBD and THC cannabis oil extracts expected to be available for commercial sale during the second half of 2019.

The company has developed a cultivation model that will be svcaled by including third party Contract Growers in order to increase the production available without the need for additional future capital investment.

Christian Toro, CEO, stated: "Our public listing in Canada marks the accomplishment of another important milestone for Blueberries as we continue to execute on our vision of becoming a leading producer of premium quality medicinal cannabis products internationally. Combining Canadian leadership in the cannabis industry, strategic global relationships and Colombian passion and expertise, at Blueberries Medical we do things better."

The shares are trading at $0.45.

For more information please visit the company’s website www.blueberriesmed.com, contact Camilo Villalba, COO, in Columbia at 57-1-345-5678 or email contacto@blueberriesmed.com.


I’m Samantha Deutscher for Investmentpitch Media